ライフサイエンスコーパス: negative result

1 tis diagnoses (both false positive and false negative results).

2 e-existing PVD at the time of surgery (false-negative results).

3 ikely to have confirmed IC than those with a negative result.

4 s negative it was 66.66-100% efficient for a negative result.

5 between a false-positive result and a false-negative result.

6 reduced the need for repeat testing after a negative result.

7 ion in spa, which produced a false S. aureus-negative result.

8 microbial resistance genes can lead to false-negative results.

9 -Plus and QFT-GIT, with 19% positive and 75% negative results.

10 microbiological culture techniques had shown negative results.

11 to organism ID, AST report, and preliminary negative results.

12 atalyze the reverse direction to avoid false negative results.

13 t could help exclude false-positive or false-negative results.

14 d HIV subtype were not associated with false-negative results.

15 pe claim on an independent set of data, with negative results.

16 More than 99% had clear negative results.

17 h positive CSF hCMV-PCR and 115 (84.6%) with negative results.

18 spatial attention tasks have mostly yielded negative results.

19 ing in increases in false-positive and false-negative results.

20 ult in weak antibody binding and cause false-negative results.

21 nts are often hampered by false positive and negative results.

22 cal implications of false-positive and false-negative results.

23 Only 6 RCTs (6.5%) reported negative results.

24 potentially causing false-positive and false-negative results.

25 s, BiFC can produce false positive and false negative results.

26 mised trials in drug resistant epilepsy with negative results.

27 25 of 25 true-negative samples (100%) showed negative results.

28 %; P < 0.01), with an equivalent increase in negative results.

29 ed from the transfer inoculum to avoid false-negative results.

30 AS pharyngitis and obviate backup testing on negative results.

31 positive results per volume in patients with negative results.

32 nfit newly diagnosed, patients risks falsely negative results.

33 ay, although all conventional tests provided negative results.

34 sting interval to 3 years if both tests have negative results.

35 Special stains for organisms demonstrated negative results.

36 ical potential but give high levels of false-negative results.

37 antities because of the high number of false-negative results.

38 RA binding experiments with this domain gave negative results.

39 ies but can lead to false-positive and false-negative results.

40 se-positive results without generating false-negative results.

41 e-positive results, and 44 (73%) had 0 false-negative results.

42 levels were independent predictors of false-negative results.

43 y, more toxic Hg species were evaluated with negative results.

44 challenge tests with the culprit drug yield negative results.

45 stains for an infectious cause demonstrated negative results.

46 ecurrent HCV RNA-positive tests after serial negative results.

47 produced 99.1% true-positive and 97.2% true-negative results.

48 atively increased risk of false-positive or -negative results.

49 Most patients in this series showed culture-negative results.

50 ase in the test line (T) intensity and false-negative results.

51 d not ensure complete ascertainment of false-negative results.

52 retransplant COVID-19 testing, all returning negative results.

53 mount of useful data by adding reliable true-negative results.

54 shold 8-OHdG value that would minimize false-negative results.

55 clinical trial of AV-101 in depression found negative results.

56 ith one of these compounds, leading to false negative results.

57 entify limitations and potential reasons for negative results.

58 of patients with true and false positive and negative results.

59 egative, zero false-positive, and zero-false negative results.

60 cal implications of false positive and false negative results.

61 Rates of false-negative results (1.0 to 1.5 per 1000 women) and recomme

62 Of 68 negative results, 10 included comments on decreased sens

63 Of 700 examinations, 205 had negative results (117 of 350 in the FI group and 88 of 3

64 tests in 106 unique patients with an initial negative result, 134 (92.4%) tests and 98 (92.5%) patien

65 Most of the patients with false-negative results (18/19) were classified as inactive chr

66 e loads >1 log10 unit higher than those with negative results (2.88 vs 1.66, P < .0001).

67 69 subjects with PDFF values less than 5.0% (negative result), 22 were determined to have steatosis b

68 Of 8,227 individuals with a negative result, 4.4% (n = 361) converted their QFT resu

69 Of 115 specimens with indeterminate or negative results, 46.1% (n = 53) were B. pertussis posit

70 e literature is limited by underreporting of negative results, a lack of out-of-sample validation, an

71 current or persistent EMPD; causes for false-negative results according to their location, histopatho

72 d test results, including 13 with an initial negative result and 15 with an initial positive result.

73 68 (75.6%) were correct; there were 20 false-negative results and 2 false positives.

74 <100/muL, which accounted for 75.7% of false-negative results and 33.3% of PCR-detectable infections,

75 samples during the Games 2016, from clearly negative results and adverse findings for testosterone (

76 ing MR imaging may thus help to reduce false-negative results and improve risk assessment.

77 eral subsequent screening colonoscopies have negative results and no new cases of CRC are found in fa

78 ons to examine the association between false-negative results and participant, clinical, and testing-

79 Rates of false-positive and false-negative results and recommendations for additional imag

80 ate-onset Pompe disease often leads to false-negative results and subsequent delays in identification

81 ography may receive false-positive and false-negative results and subsequent imaging and biopsies.

82 at PFGE is prone to false-positive and false-negative results and suggests the need for a new gold st

83 dle by volume (7-gauge) resulted in no false-negative results and that combining imaging and image-gu

84 equired to rule out the possibility of false negative results and there is currently a shortage of RT

85 th Hybrid Capture 2 (HC2)-positive, cytology-negative results and who were age >/=30 years from Kaise

86 tached vitreous at the time of surgery (true-negative results), and 8 eyes had pre-existing PVD at th

87 .1%) had nonosteoporotic T-scores (DXA false-negative results), and most (97%) had L1 or mean T12 to

88 25%) had a positive result, 81 (65.3%) had a negative result, and 12 (9.7%) had an indeterminate resu

89 ites in bones or organs, Eleven patients had negative results, and 9 patients showed indeterminate le

90 Clearance was defined as 3 consecutive negative results, and blips as isolated positive results

91 se programs will need to be aware that false-negative results are a possibility.

92 Rates of false-negative results are low.

93 trials are widely hailed, while trials with negative results are often interpreted as scientific fai

94 We find that unless a sufficient fraction of negative results are published, false claims frequently

95 Only studies predating 1990 reported negative results as a result of insufficient magnitude o

96 timate of the 'true' TE by controlling false negative results associated with excessively high placeb

97 n, 2.27 ng/mL; range, 0.2-27.45 ng/mL) and a negative result at conventional imaging (bone scan and/o

98 f Radiology breast density category 4) and a negative result at mammography (Breast Imaging Recording

99 fects of re-treatment, the percentage of UBT-negative results at 1 year was 72.4% (95% CI, 69.9%-74.8

100 g-detected cancers, and 52 examinations with negative results at 1-year follow-up.

101 ac disease among first degree relatives with negative results at a first screening.

102 ies and the need for retesting patients with negative results at baseline.

103 One additional patient with negative results at CT pulmonary angiography had deep ve

104 ERs with positron emission tomography (PET) -negative results at response assessment.

105 Women with negative results at the last screening visit (year 11) e

106 Should negative results become easier to publish as a claim app

107 fied as containing borderline color results (negative result but with no package insert color visible

108 The sample with a false-negative result by CrAgSQ (n = 1) had a titer of <1:5, w

109 s for whom a dry nasal swab specimen yielded negative results by IDNOW had a paired nasopharyngeal sw

110 r lavage samples taken from patients who had negative results by routine respiratory virus testing to

111 onal patients testing positive by us-RDT had negative results by us-qPCR.

112 Potential reasons for the negative results can be classified into three categories

113 Negative results can be used to rule out celiac disease

114 Moreover, false-positive or false-negative results can occur.

115 sinolates and growth, this is likely a false negative result caused by the limited population size.

116 concentrations and risk of false positive or negative results caused by mixed spectra.

117 ducts that appear to transmit core antibody, negative results correlated with lower surface antibody

118 a nucleic acid detection method; however, a negative result does not exclude infection due to the lo

119 s in resting-state connectivity may be false-negative results driven by a neurovascular uncoupling me

120 The pitfalls involve potential false-negative results due to blurring or missing lesions or f

121 , clinical trials for RP treatments may give negative results due to multiple disease mechanisms with

122 ential for preventing the reporting of false-negative results due to the high-dose "hook" effect.

123 there was a single false-positive and false-negative result each, for a sensitivity and specificity

124 This negative result explains why solvent additives mixtures

125 ese criteria can lead to high rates of false negative results, FN.

126 fixation losses (FLs) of 33% or less, false-negative results (FNRs) of 20% or less, and false-positi

127 previously negative ThinPrep vials yielded a negative result following routine automated cytology pro

128 pertussis by the FilmArray RP and one false-negative result for both the Aries BA and the FilmArray

129 ples containing Streptococcus pyogenes and a negative result for those without.

130 ve test result but second blood sample had a negative result for tTGA were older, had lower-than-aver

131 tuberculosis incidence than children with a negative result for tuberculosis infection, and this inc

132 itivity in fewer than 5% of cells and showed negative results for adipophilin.

133 history of asthma/allergic rhinitis: all had negative results for aeroallergen skin prick tests.

134 Both assays gave negative results for all non-CP isolates and positive re

135 ls, squamous carcinomas and melanomas showed negative results for androgen receptors and adipophilin.

136 nterval between screening colonoscopies with negative results for average-risk individuals.

137 amous carcinomas and melanomas, which showed negative results for both, and from basal cell carcinoma

138 en (43.8%) with positive and 42 (20.3%) with negative results for HCMV DNAemia (P = .006; odds ratio,

139 d were classified as cases and 117 (59%) had negative results for HIV and were classified as controls

140 her exact test) compared with tumors showing negative results for HPV-16.

141 Among the 78 subjects with negative results for intakes at home, 92% had no symptom

142 We randomly assigned children who had negative results for M. tuberculosis infection according

143 Most vitrectomies showed negative results for malignancy: 99.47% of TMC cases, 99

144 as MSSA by the BD Max StaphSR assay, due to negative results for MREJ.

145 retinal pigment epithelial neoplasms showed negative results for PAX8.

146 an overestimation of response (yielded false-negative results for residual disease) in 66.7% (14 of 2

147 its, approximately 2% who had previously had negative results for SARS-CoV-2 at the beginning of supe

148 ollected at the first time point, 15,398 had negative results for tTGA, and 153 had positive results

149 The often negative results for WNV by current RT-PCR and serologic

150 tcome was combined clinical resolution and a negative result from a polymerase chain reaction test fo

151 ommended in the short-term, for cases with a negative result from CE, the impact of CE on long-term r

152 Forty-nine (0.32%) individuals with a negative result from the first serologic test for tTGA h

153 ify diagnoses of non-DMD disorders and false negative results from 1975 to July 12, 2015.

154 ded adults after blunt traumatic injury with negative results from a well-interpreted, high-quality C

155 , we found that fewer than 1% of adults with negative results from an initial test for tTGA have a po

156 This could not only help explain negative results from anti-Abeta clinical trials but als

157 ng number of reports about false positive or negative results from conventional cytotoxicity assays o

158 Classical food allergies were excluded by negative results from immunoglobulin E serology analysis

159 without diagnoses of celiac disease or have negative results from second tests.

160 of patients with suspected enteropathy, but negative results from serologic tests for celiac disease

161 r patients with suspected celiac disease but negative results from serologic tests, total IgA level s

162 other enteropathies unrelated to gluten, but negative results from serologic tests.

163 patients with suspected celiac disease, but negative results from serologic tests.

164 peripheral blood monocytes, despite constant negative results from tests for HCV RNA in serum.

165 The combination of clinical resolution and negative results from the test for CD were observed in 1

166 CIN3+, while women with HC-2 positive/HPV16-negative results had a much lower risk of 2.4%.

167 The 2 (68)Ga-THP-PSMA scans with negative results had only 1+/2+ staining.

168 Considering the negative results here reported, six independent laborato

169 Despite having negative results, HN.6 has contributed important data re

170 e with instructions, providing a positive or negative result in 20 min.

171 broth culture enrichment resulted in 1 false-negative result in 68 (1.5%).

172 om onset (day 5), the probability of a false-negative result in an infected person decreases from 100

173 6% of the time but proceeded despite phase 2 negative results in 10 cases.

174 results in 26% (five of 19 patients), false-negative results in 11% (two of 19 patients) and by guid

175 mentous fungi in 19 samples (27%) and showed negative results in 13 samples (19%).

176 sentinel lymph node would have led to false-negative results in 19 of 475 (4%) of all patients and 1

177 in testing for vancomycin sensitivity showed negative results in 3 patients and was not performed in

178 PSMA PET had negative results in 34.6% (90/260), showed disease confi

179 The criteria resulted in false-negative results in 8 (1.9%) patients, 6 of whom were bo

180 and sample type, Abbott ID Now COVID-19 had negative results in a third of the samples that tested p

181 Of these patients, 17 (19%) had negative results in all molecular tests and were therefo

182 proach for urine screening and might produce negative results in as few as 3 h, with no downstream wo

183 There was no difference in positive and negative results in comparisons of fresh and stored samp

184 erformance and factors contributing to false-negative results in longitudinal studies, we examined re

185 After negative results in screening for mutations in candidate

186 act clearance mechanisms bring into question negative results in single-gene knockout mice.

187 6%, depending on the unknown number of false-negative results in single-tested patients.

188 PET/CT provided false-positive and false-negative results in six and three patients (PPV, 81% [26

189 Is other than the culprit PPI that displayed negative results in skin tests (n = 61) and diagnostic O

190 ver standard PCR assays which generate false-negative results in such situations.

191 Specimens with indeterminate or negative results in the CDC PCR were tested using an alt

192 However, the risk of PET false-negative results in the presence of carbidopa is a conce

193 5%), and 77.8% (95% CI, 73.6%-81.6%) had UBT-negative results in the triple, sequential, and concomit

194 tion tests were performed to 4 cases who had negative results in the wheat + exercise test.

195 lihood of empirical therapy leading to false-negative results in these patients.

196 Toxicity assays yield negative results in three cell lines, suggesting that pr

197 ons, with 10 false-positive and only 2 false-negative, resulting in a lesion-based detection rate for

198 The CryptoPS false-negative results included samples with titers of <1:5 (n

199 ems associated with false-positive and false-negative results, inconsistencies and low reactivity of

200 indicator of acute stress is prone to false negative results, increasing in some stressful situation

201 ss-reactivity have been reported and because negative results indicate tolerability.

202 This negative result is surprising, given the importance of t

203 respectively, suggesting that a positive or negative result is unable, on its own, to confirm or exc

204 uman papillomavirus (HPV)-positive, cytology-negative results is critical to the introduction of HPV

205 As an important negative result, it can be concluded that gliosis is not

206 These negative results lead us to search for specific mechanis

207 w-up of reported pertussis patients with PCR-negative results leads to the detection of more true per

208 PET/CT result for tumor and those who had a negative result (log-rank, P < 0.0001), with a hazard ra

209 99) presented the lowest proportion of false-negative results (low certainty in the evidence).

210 ed morbidity, fewer false-positive and false-negative results, lower-cost, and higher analytical freq

211 g of all producers of ESBLs and also falsely negative results may occur with isolates that coproduce

212 col in many randomized controlled trials and negative results may reflect the failure to implement th

213 The negative results might be owing to the effects of smokin

214 onfirmed harm to child and parent related to negative results/no diagnosis, two (2%) reported stress

215 5.7%-63.0%), corresponding to 6 of 874 false-negative results (none met treatment criteria).

216 s a mathematical approach to limit the false negative results occuring with the use of other normaliz

217 False-negative results occurred in patients with PTLD in the W

218 erval [CI], 99.1%-99.6%) with a mean time to negative result of 4.2 +/- 0.9 hours.

219 e for food allergen, and to be careful about negative result of prick test.

220 If this test result is negative, a false-negative result of the mutation analysis should be consi

221 aving achieved viral suppression if they had negative results of at least 1 subsequent HCV RNA test.

222 Negative results of atherosclerosis-imaging tests, parti

223 tility in mitigating false positive or false negative results of direct SARS-CoV-2 tests.

224 can have a relapsing course providing false negative results of endoscopy and ultrasound if performe

225 After negative results of endoscopy and ultrasound, the diagno

226 rriers, and healthy control subjects who had negative results of rapid diagnostic tests.

227 Patients with negative results of reverse-transcription polymerase cha

228 HT signaling axis that help to interpret the negative results of the Baminercept trial and will guide

229 this issue of Blood, Petersdorf et al report negative results of the phase 3 study designed by the So

230 iuretics and the likelihood of a positive or negative result on Covid-19 testing as well as the likel

231 l fluid testing showed normal cell counts, a negative result on reverse-transcription polymerase chai

232 months, the proportion of subjects who had a negative result on testing with the target dose (20g dri

233 report negative results on a randomized clinical trial testing

234 bone lesions in 8 of 38 (21%) patients with negative results on bone or (18)F-NaF PET scans.

235 8% and 96.4%, respectively, among those with negative results on colonoscopy (P<0.001).

236 PSA], 2.5 ng/mL; range, 0.21-35.5 ng/mL) and negative results on conventional imaging after primary l

237 calization only on (18)F-DCFPyL PET, despite negative results on conventional imaging.

238 ad an undetectable HBV viral load, and 3 had negative results on HBsAg testing and had an undetectabl

239 cond-line imaging strategy for patients with negative results on initial imaging with CT/MRI.

240 ilities to tell women with dense breasts and negative results on screening mammography to discuss sup

241 atients, the treatment was continued despite negative results on standard (18)F-FDG PET and negative

242 vice versa, obtaining the second test after negative results on the first seems justified when detec

243 ention-to-treat population who initially had negative results on the skin-prick test, the prevalence

244 tment response to SRT was higher in men with negative results or disease confined to the PF than in m

245 of those who received sRT, 81% (81/100) with negative results or fossa-confined findings versus 45% (

246 nosis, especially when PCR is delayed, shows negative results, or is not available.

247 xty patients fluctuated between positive and negative results over several weeks, suggesting that cau

248 ive results compared with 104 (44%) after of negative results (p<0.0018).

249 eady for discharge and who had 2 consecutive negative results per nucleic acid amplification testing

250 Negative results presented in the past few years, howeve

251 with FilmArray GI panel within 4 weeks of a negative result rarely changed the initial result, and t

252 on, we consider the possible reasons for the negative results regarding the progression of DR in the

253 east cancer is unclear because of high false-negative results reported in previous studies.

254 ely to produce both false-positive and false-negative results, resulting in an inaccurate and incompl

255 e a >95% level of confidence in positive and negative results, suggesting that when multiple samples

256 n in patients with GCA giant cell arteritis -negative results ( TAB temporal artery biopsy subcohort

257 mucoperiosteal flap gave significantly more negative results than that of the less-demanding flaples

258 including the clinical implications of false-negative results), the exclusion of transmission effects

259 Despite the negative result, the trial does provide information that

260 r complete sequencing of the ABCA4 gene with negative results, the screening for disease-causing muta

261 Regarding "false negative" results, this possibility maybe verified for a

262 roficiency assessment suggested positive and negative results to be reliable.

263 Furthermore, we call for more sharing of negative results to inform the TMD peptide field, which

264 Although negative results typically prompt revaccination, failure

265 on lipid-modification end points followed by negative results using clinical end points.

266 Other nontarget bacteria show negative results, verifying the high specificity of the

267 present (10 fungus, 1 Acanthamoeba) but had negative results via culture and light microscopy.

268 In 19 of the 37 cases (51.4%), the false-negative result was potentially avoidable.

269 r those with AHPV-negative compared with HC2-negative results was 0.9 (95% CI, -0.2 to 2.1) per 1,000

270 among all women with HC2-positive, cytology-negative results was 4.6%.

271 The percentage of examinations with negative results was tabulated for both groups, and the

272 al data, suggesting that the reasons for the negative result were less likely related to the biologic

273 sitive results and 26 people with concordant negative results were analyzed via the highly multiplexe

274 ith aztreonam and carbapenems; subjects with negative results were challenged with escalating doses o

275 False-negative results were confirmed in the Waldeyer's ring,

276 true- and false-positive and true- and false-negative results were extracted to fit a cross-tabulatio

277 False-negative results were found in 2 patients and occurred a

278 No false-negative results were found.

279 taminated sample evaluations showed no false negative results were generated from a variety of differ

280 the individual sample-positive/pooled sample-negative results were likely due to the M. tuberculosis

281 False-negative results were minimized in these test definition

282 xhibited low temporal variability, (b) false-negative results were not obtained, (c) the indoor air c

283 All (16/16) CryptoPS false-negative results were obtained for samples with IMMY tit

284 Negative results were obtained for the 9-6 haplotype, th

285 marker peptides, no false-positive or false-negative results were obtained.

286 each grain species and no false-positive or -negative results were obtained.

287 Two false-negative results were related to poorly differentiated d

288 Additional tests, including negative results, were retrospectively collected.

289 rasitemia, and PfHRP-II tests can give false-negative results when P. falciparum strains do not expre

290 e, and thus lead to false positive and false negative results when the number of non-zero values is s

291 nd eGFR >= 50 ml/min/1.73m(2) (i.e. a "false negative" result when only determining eGFR).

292 cently, there has been a growing interest in negative results, which has resulted in negation detecti

293 anel positive and myco/f lytic blood culture negative results, while 6 patients had T2Candida panel n

294 Among participants with UBT-negative results who had a 1-year follow-up UBT (n=1091)

295 .8%), there were larger proportions of false-negative results with 1.0 ml (29.4%; P = 0.2) and 1.2 ml

296 of normal human kidney, in contrast with the negative results with 20 control serum samples.

297 There were 49 cases of RDT false-negative results with a parasite density range of 40-54

298 Overall, these negative results with bupropion and risperidone are conc

299 Seven of the 1982 patients (0.4%) had false-negative results with the staged algorithm.

300 The AST systems showed false-negative results with varying numbers, misidentifying me